Home Page News Opinion Foreign Policy Politics Policy Legislation Lobbying Hill Life & People Hill Climbers Heard On The Hill Calendar Archives Classifieds
Hill Times Events Inside Ottawa Directory Hill Times Books Hill Times Careers The Wire Report The Lobby Monitor Parliament Now
Subscribe Free Trial Reuse & Permissions Advertising
Log In
Policy Briefing: LIFE SCIENCES

Federal biotech regulation challenged by rapid innovation in life sciences

Industry stresses need for a streamlined regulatory framework and harmonization at the international level.
Skilled workforce and collaboration play key roles in Ottawa's expanding life sciences sector, but industry says attracting outside experts remains an obstacle.
Conservatives have long-touted the GHG reductions that would result from investing government money in developing ethanol as a supplementary fuel to gasoline.
Federal and provincial governments currently give pharmaceutical companies tax breaks and subsidies to encourage them to devote more of their budgets to developing new drugs.

Your group subscription includes premium access to Politics This Morning briefing.